Johnson &amp; Johnson&#39;s Weldon Shifts Focus to Devices From Drugs
16804
Johnson &amp; Johnson Chief Executive Officer William Weldon plans to use the $25 billion purchase of defibrillator maker Guidant Corp.
561495
Dec. 19--Pfizer, the world&#39;s biggest drug maker, and the rest of the pharmaceutical sector will come under renewed pressure this week after the Food and Drug Administration (FDA) warned doctors to consider
615822
When Merck&#39;s arthritis drug Vioxx was withdrawn from the market in September, concerns over drug safety were pretty much under the radar for the most part, but not today.
561889
By Sabine Vollmer, The News & Observer, Raleigh, N.C.  Sep. 9--Peyton Anderson has big plans for Affinergy, the three-year-old medical device company he runs in south Durham.
225711
Johnson &amp; Johnson has made dozens of mostly small acquisitions over the last decade, expanding its portfolio of more than 200 businesses that make products like Band-Aids, artificial knees and blockbuster drugs.
314927
The move may mark the beginning of a bigger retrenchment by Pfizer and the rest of the drug industry.
433075
When pharmaceutical giant Merck &amp; Co. abruptly pulled its arthritis pain medication Vioxx from the marketplace on Sept. 30, more than 2 million patients were taking the drug.
667631
The prospect of Johnson &amp; Johnson acquiring Guidant, a medical device maker that brought cutting-edge technology to cardiovascular medicine, has fueled whispers for years, gaining intensity when
764344
The anti-industry crusader targets pharmaceuticals.
181860
Platforms have the potential to develop multiple drugs for a company.
661105
US health titan Johnson and Johnson has reached a deal to acquire US heart device manufacturer Guidant Corporation, in a stock-and-cash deal valued at $23.9 billion, based on $76 a share, the companies said in a statement early this morning.
455781
It has been a long and tortured courtship. For years, health-care giant Johnson &amp; Johnson (JNJ ) has held on-again, off-again acquisition talks with medical-device maker Guidant (GDT ). Now Wall Street sources say the companies are talking again.
482241
The drugmaker bumps into the FDA as it pushes to do more testing of Entereg.
20190
With new warnings on an abortion pill, the Food and Drug Administration has given conservative medical advice. Whatever factors may have gone into the change, the FDA must focus on science, not conservative politics.
496294
The withdrawal of Merck &amp; Co. Inc.&#39;s arthritis drug Vioxx will make it harder for drug companies to win approval for products aimed at big patient populations as regulators
119342
The Food and Drug Administration launched an effort this week to use radio frequency identification technology to track the nation&#39;s drug supply from manufacturer to pharmacy to reduce counterfeiting.
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.